Template:Ceftriaxone: Difference between revisions
Jump to navigation
Jump to search
Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8..." |
No edit summary |
||
| Line 2: | Line 2: | ||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ceftriaxone|{{fontcolor|#6C7B8B|Ceftriaxone}}]]''''' | ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ceftriaxone|{{fontcolor|#6C7B8B|Ceftriaxone}}]]''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |CEFTRIAXONE<sup>®</sup> FDA Package Insert | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left |CEFTRIAXONE<sup>®</sup>,ROCEPHIN<sup>®</sup> FDA Package Insert | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftriaxone description|Description]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftriaxone description|Description]] | ||
Revision as of 15:48, 31 December 2013
| Ceftriaxone |
|---|
| CEFTRIAXONE®,ROCEPHIN® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| Clinical Studies |
| How Supplied |
| Labels and Packages |